Press "Enter" to skip to content

Glaukos Corp., with its Pharmaceutical Platform that Delivers UV Light to the Cornea, Delivers its Current Report to SEC

Glaukos Corporation delivered its Form 8-K Current report to the U.S. Securities and Exchange Commission on February 22, 2022. Glaukos Corp. is an ophthalmic medical…
This content is viewable by members only. Visit My Account to login or register for a 30 day free trial or Shop to make a purchase.